Find out now if you qualify. Time is limited to file a claim. You may be entitled to compensation. Fill out the form below to see if you qualify.

Did you use Suboxone Film strips for at least 6 months prior to 2022? *

Did your teeth start to decay after using Suboxone? *

Do your dental problems involve at least 5 teeth? *

What state did you live in while using Suboxone Film strips? *

Do you currently live in the same state? *

Have you retained an attorney yet for this claim? *

First Name *

Last Name *

Email Address *

Phone Number *

Tell Us About Your Teeth *

Free Claim Review

By clicking the “Submit” button below, I hereby grant my express written consent and authorize Tort Group LLC, and its affiliates and law firm partners, to contact me about their services at the phone number and email address provided above/below. I consent to receive telemarketing calls and text messages using an automatic telephone dialing system or prerecorded voice. I understand that the express written consent I provide here is not required in order to purchase any good or service. I also acknowledge and agree to the Terms & Conditions. Text Message frequency may vary. Message & Data rates may apply. You may opt-out of SMS at any time by replying STOP to the phone number we texted you from. Reply HELP for help to the phone number we texted you from.. You may view our Privacy Policy here.

We are here to listen and help.
Submit below to speak with our team.

Ronnie Roman Sexual Abuse Claim Help

Suboxone Tooth Decay

Compensation For Victims

Suboxone Film Linked to Tooth Decay

Information submitted will be transmitted to a law firm. This communication is intended to be an attorney-client communication for purposes of evaluating your claim and will be kept confidential by the law firm. The communication does not create an attorney-client relationship and no relationship is formed until a fee agreement is signed by you and the law firm. I also have read and agree to your Privacy Policy

File Your Claim Now

April 2022: The MDL Paraquat class action judge will have a status conference on April 1st to review where the litigation is headed and how best to take the bellwether lawsuits forward for trial in November 2022. 44 new paraquat lawsuits have been added to the MDL in the last two weeks. At this pace, April 2022 will be the busiest month for new files yet. Last week, the parties filed their class-action bellwether picks with the Paraquat MDL judge. Those choices, however, have not been made public.

May 2022: In the last month, over 50 new cases have been added to the Paraquat Lawsuit Multidistrict Litigation (MDL). A group of six patients was recently selected by the Paraquat MDL court for the initial Paraquat Parkinson's disease bellwether trials. As a result, the first trial in November 2022 is approaching soon. The strategy is to select 16 paraquat claims from among the almost 1000 Parkinson's disease litigation claims filed. Following some limited fact discovery in these instances, paraquat attorneys on both sides submitted a preference list to the MDL court, ranking the 16 cases in order of priority. Attorneys for plaintiffs seek the finest facts for their clients, while defense attorneys want the worst. The judge whittled the list down to six Paraquat claims based on these rankings.

CLAIM UPDATES

We are here to listen and help answer all your questions. Contact us today for a Free Claim Review by filling out the form above.

Studies & Settlements

Anyone who has suffered dental injuries after sublingual Suboxone usage should contact us now. Seek the justice and closure you deserve.

Significant compensation may be available. Free Claim Review.

Seek Justice Today

Maryland Juvenile Detention

Abuse Claim Help

Jeff Brandow

Sexual Abuse

Claim Help

File Your Claim Now

Suboxone, a medication combining buprenorphine and naloxone, is widely used to treat opioid use disorder. Administered as a sublingual film dissolved under the tongue or inside the cheek, it has been associated with significant dental issues. In January 2022, the U.S. Food and Drug Administration (FDA) issued a warning highlighting reports of dental problems, including tooth decay, cavities, oral infections, and tooth loss, linked to buprenorphine medications dissolved in the mouth. Indivior, the manufacturer of Suboxone, has faced criticism and legal challenges for failing to adequately warn patients about the severe dental risks associated with the sublingual film. Patients allege that Indivior did not provide sufficient warnings about these potential side effects, leaving them unaware of the need for enhanced oral care while using the medication. This lack of transparency has led to numerous lawsuits, holding the company accountable for its insufficient patient guidance.

A study published in the Journal of the American Medical Association (JAMA) analyzed health claims data to assess the association between sublingual Suboxone and dental adverse events. The findings indicated a higher incidence of dental issues among users of sublingual buprenorphine/naloxone compared to those using transdermal buprenorphine or oral naltrexone.

"Trust our experienced team to handle your claim with care and commitment. Contact us today for reliable legal support."

Our dedicated team will fight for your rights and compensation. Confidentiality, Safety, & Justice are our top priorities

How to Qualify for a Depo-Provera Claim:
Use of Depo-Provera
Diagnosis of Brain Tumor
Document Evidence
Submit The Form Above

Depo-Provera is an injectable birth control containing the synthetic hormone medroxyprogesterone acetate, is linked to an increased risk of meningioma, a rare brain tumor. This risk was not adequately disclosed to consumers or medical professionals. Studies, including those published in the Journal of the American Medical Association (JAMA), have shown that long-term use of Depo-Provera significantly raises the risk of developing meningiomas.

Claims against Pfizer, Inc., the drug’s manufacturer, alleges that the company knew or should have known about the increased risk of meningiomas—brain tumors that can cause severe neurological symptoms—especially with prolonged use. The claims state that Pfizer failed to adequately warn doctors and patients, rushed the drug to market without sufficient long-term studies, and prioritized profits over safety.

Due to the rising number of claims against Pfizer regarding Depo-Provera and brain tumors have been consolidated into multidistrict litigation (MDL) in federal court. Affected individuals may seek compensation for medical expenses, long-term care, and other damages, with the potential for federal court consolidation of cases.

In response to these concerns, numerous lawsuits have been filed against Indivior, the manufacturer of Suboxone, alleging failure to adequately warn patients and healthcare providers about the risk of severe dental problems. In July 2024, Indivior agreed to an $86 million settlement with 16 U.S. states, including allegations related to issues surrounding Suboxone.

Anyone who used the Suboxone Sublingual Film for at least 6 months prior to 2022, and has developed significant dental issues, please fill out the form above for a Free Claim Review.

Deadline to file is approaching.

Cavities

Fractures

Cracking

Deterioration

Extractions

Root Canals

Oral Ulcers

Oral Lesions

Injuries Include: